A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Incyte Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 9,260 shares of INCY stock, worth $653,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,260
Previous 11,166 17.07%
Holding current value
$653,200
Previous $676,000 9.47%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$57.33 - $68.61 $109,270 - $130,770
-1,906 Reduced 17.07%
9,260 $612,000
Q2 2024

Aug 14, 2024

SELL
$51.18 - $63.75 $355,956 - $443,381
-6,955 Reduced 38.38%
11,166 $676,000
Q1 2024

May 15, 2024

BUY
$56.55 - $66.59 $1.02 Million - $1.21 Million
18,121 New
18,121 $1.13 Billion
Q4 2023

Aug 14, 2024

BUY
$52.16 - $64.19 $603,021 - $742,100
11,561 Added 202.5%
17,270 $1.08 Billion
Q3 2023

Aug 14, 2024

BUY
$57.77 - $65.93 $22,010 - $25,119
381 Added 7.15%
5,709 $330 Million
Q2 2023

Aug 14, 2024

SELL
$60.95 - $75.51 $872,682 - $1.08 Million
-14,318 Reduced 72.88%
5,328 $332 Million
Q1 2023

Aug 14, 2024

BUY
$70.23 - $86.01 $932,443 - $1.14 Million
13,277 Added 208.46%
19,646 $1.42 Billion
Q2 2022

Aug 14, 2024

BUY
$66.18 - $83.18 $15,155 - $19,048
229 Added 3.73%
6,369 $484 Million
Q1 2022

Aug 14, 2024

SELL
$66.02 - $79.71 $331,816 - $400,622
-5,026 Reduced 45.01%
6,140 $488 Million
Q4 2021

Aug 30, 2024

SELL
$63.34 - $74.11 $7,600 - $8,893
-120 Reduced 1.91%
6,165 $452 Million
Q3 2021

Aug 30, 2024

BUY
$68.67 - $84.02 $8,240 - $10,082
120 Added 1.95%
6,285 $432 Million
Q2 2021

Aug 30, 2024

SELL
$79.87 - $87.53 $399,429 - $437,737
-5,001 Reduced 44.79%
6,165 $518 Million
Q1 2021

Aug 30, 2024

BUY
$76.02 - $100.5 $6,765 - $8,944
89 Added 1.46%
6,165 $501 Million
Q4 2020

Aug 30, 2024

BUY
$80.74 - $97.7 $439,710 - $532,074
5,446 Added 864.44%
6,076 $529 Million
Q3 2020

Aug 30, 2024

SELL
$85.07 - $109.69 $5,954 - $7,678
-70 Reduced 10.0%
630 $56.5 Million
Q2 2020

Aug 30, 2024

SELL
$74.18 - $108.93 $3,709 - $5,446
-50 Reduced 6.67%
700 $72.8 Million
Q1 2020

Aug 30, 2024

SELL
$63.18 - $85.97 $22,428 - $30,519
-355 Reduced 32.13%
750 $54.9 Million
Q4 2019

Aug 30, 2024

BUY
$73.04 - $95.72 $25,564 - $33,502
350 Added 46.36%
1,105 $96.5 Million
Q3 2019

Aug 30, 2024

SELL
$72.82 - $86.52 $32,841 - $39,020
-451 Reduced 37.4%
755 $56 Million
Q2 2019

Aug 30, 2024

BUY
$73.52 - $88.7 $31,319 - $37,786
426 Added 54.62%
1,206 $102 Million
Q1 2019

Aug 30, 2024

BUY
$63.56 - $88.17 $24,152 - $33,504
380 Added 95.0%
780 $67.1 Million
Q4 2018

Aug 30, 2024

SELL
$58.5 - $69.94 $629,811 - $752,974
-10,766 Reduced 96.42%
400 $25.4 Million
Q2 2018

Aug 30, 2024

SELL
$60.85 - $83.98 $15,212 - $20,995
-250 Reduced 38.46%
400 $26.8 Million
Q1 2018

Aug 30, 2024

BUY
$83.06 - $100.98 $28,987 - $35,242
349 Added 115.95%
650 $54.2 Million
Q4 2017

Aug 30, 2024

SELL
$93.56 - $116.6 $14,969 - $18,656
-160 Reduced 34.71%
301 $28.5 Million
Q3 2017

Aug 30, 2024

SELL
$109.15 - $138.27 $49,990 - $63,327
-458 Reduced 49.84%
461 $53.8 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-10,247
919 $116 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.7B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.